Skip to main content
Premium Trial:

Request an Annual Quote

In LoBosco's World, All Software Is Enticing

Premium

For Rob LoBosco, it seems there’s no IT problem that isn’t intriguing. His latest challenge comes in the form of Seattle-based Life- Span BioSciences, where he’s the new chief information officer. He’ll be in charge of building the IT infrastructure for the company, as well as choosing “the right technologies and platforms” to keep it heading in a positive direction while anticipating the growth in the pharma and biotech industry.

LifeSpan, which currently has about 150 employees, sells various versions of its drug target database. According to LoBosco, 35, smaller biotechs usually buy a portal that includes GPCR targets, while pharmas get a more comprehensive package that also has gene families and antibodies.

LoBosco’s pharma experience comes from a few years at Merck’s IT department. “The Merck experience introduced me to a very large company dealing with a global environment and a very large IT budget,” he says. He left in 1999 “to work on some of the dot-coms that were starting at the time,” he says — including HotJobs — ruefully adding that one or two “became dot-bombs.”

Previously, he worked on satellite programs for NASA. But LoBosco’s software engineering career began at Sikorsky Aircraft, which he joined as a junior in college and stayed at after graduation. He primarily worked on helicopter simulation programs: “much like very large, very expensive video games,” he says.

— Meredith Salisbury

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.